Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients

Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients - Analysis of vaginal and uterine microbiota of infertile and recurrent miscarriage patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031731

Enrollment

100

Registered

2018-03-15

Start date

2017-10-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility and recurrent miscarriage

Interventions

vaginal and uterine cavity secretion and endometrial tissue collection from test subjects vaginal and uterine cavity secretion and endometrial tissue collection from test subjects after treatments b

antibiotics&gt

1. doxycycline 200mg (100mg tablet, twice a day) for 14 days 2. ciprofloxacin 600mg(200mg tablet, three times a day) for 10 days 3. amoxicillin 1000mg(250mg capsule, four times a day) for 8 days

probiotics/prebiotics&gt

1. lactoferrin 700mg(100mg seven tablets, once time a day ) for more than four weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Infertile patients requiring artificial reproductive technology and recurrent miscarriage patients

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The association between microbiota and implantation rate and livebirth rate.	—

Countries

Japan

Contacts

Public ContactTakuhiko Ichiyama

St.Mother Hospital Department of obstetrics and gynecology

incho@stmother.com81-93-601-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026